A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13
Investigative needle core biopsies for multi-omics in GlioblastomaKenny K.H. Yu, Nathalie Y.R. Agar, Jennifer Gantchev et al.|medRxiv|2023Cited by 6